Last reviewed · How we verify
trivalent rotavirus genetic reassortment vaccine
trivalent rotavirus genetic reassortment vaccine is a Biologic drug developed by Center for Disease Control and Prevention, Henan Province. It is currently in Phase 3 development for Prevention of severe rotavirus gastroenteritis in infants and young children.
This vaccine induces immunity against rotavirus by introducing inactivated rotavirus antigens.
This vaccine induces immunity against rotavirus by introducing inactivated rotavirus antigens. Used for Prevention of severe rotavirus gastroenteritis in infants and young children.
At a glance
| Generic name | trivalent rotavirus genetic reassortment vaccine |
|---|---|
| Sponsor | Center for Disease Control and Prevention, Henan Province |
| Modality | Biologic |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
The trivalent rotavirus genetic reassortment vaccine works by introducing inactivated rotavirus antigens to stimulate an immune response, providing protection against severe rotavirus gastroenteritis. This is achieved through the genetic reassortment of rotavirus strains, which allows for the creation of a vaccine that can induce immunity against multiple serotypes of the virus.
Approved indications
- Prevention of severe rotavirus gastroenteritis in infants and young children
Common side effects
- Fever
- Vomiting
- Diarrhea
- Injection site pain
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- trivalent rotavirus genetic reassortment vaccine CI brief — competitive landscape report
- trivalent rotavirus genetic reassortment vaccine updates RSS · CI watch RSS
- Center for Disease Control and Prevention, Henan Province portfolio CI
Frequently asked questions about trivalent rotavirus genetic reassortment vaccine
What is trivalent rotavirus genetic reassortment vaccine?
How does trivalent rotavirus genetic reassortment vaccine work?
What is trivalent rotavirus genetic reassortment vaccine used for?
Who makes trivalent rotavirus genetic reassortment vaccine?
What development phase is trivalent rotavirus genetic reassortment vaccine in?
What are the side effects of trivalent rotavirus genetic reassortment vaccine?
Related
- Manufacturer: Center for Disease Control and Prevention, Henan Province — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of severe rotavirus gastroenteritis in infants and young children